1 Market Overview

1.1 Product Overview and Scope of Migraine Headache Drugs

1.2 Classification of Migraine Headache Drugs by Type

1.2.1 Overview: Global Migraine Headache Drugs Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Migraine Headache Drugs Revenue Market Share by Type in 2021

1.2.3 Almotriptan

1.2.4 Eletriptan

1.2.5 Sumatriptan

1.2.6 Rizatriptan

1.2.7 Zolmitriptan

1.2.8 Naratriptan

1.2.9 Frovatriptan

1.2.10 Others

1.3 Global Migraine Headache Drugs Market by Application

1.3.1 Overview: Global Migraine Headache Drugs Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Acute Migraine

1.3.3 Common Migraine

1.3.4 Classic Migraine

1.3.5 Chronic Migraine

1.3.6 Other Migraines

1.4 Global Migraine Headache Drugs Market Size & Forecast

1.5 Global Migraine Headache Drugs Market Size and Forecast by Region

1.5.1 Global Migraine Headache Drugs Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Migraine Headache Drugs Market Size by Region, (2017-2022)

1.5.3 North America Migraine Headache Drugs Market Size and Prospect (2017-2028)

1.5.4 Europe Migraine Headache Drugs Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Migraine Headache Drugs Market Size and Prospect (2017-2028)

1.5.6 South America Migraine Headache Drugs Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Migraine Headache Drugs Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Migraine Headache Drugs Market Drivers

1.6.2 Migraine Headache Drugs Market Restraints

1.6.3 Migraine Headache Drugs Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Migraine Headache Drugs Product and Solutions

2.1.4 Pfizer Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Migraine Headache Drugs Product and Solutions

2.2.4 Novartis Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Johnson & Johnson

2.3.1 Johnson & Johnson Details

2.3.2 Johnson & Johnson Major Business

2.3.3 Johnson & Johnson Migraine Headache Drugs Product and Solutions

2.3.4 Johnson & Johnson Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Johnson & Johnson Recent Developments and Future Plans

2.4 GSK

2.4.1 GSK Details

2.4.2 GSK Major Business

2.4.3 GSK Migraine Headache Drugs Product and Solutions

2.4.4 GSK Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 GSK Recent Developments and Future Plans

2.5 Merck

2.5.1 Merck Details

2.5.2 Merck Major Business

2.5.3 Merck Migraine Headache Drugs Product and Solutions

2.5.4 Merck Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Merck Recent Developments and Future Plans

2.6 Eli Lilly

2.6.1 Eli Lilly Details

2.6.2 Eli Lilly Major Business

2.6.3 Eli Lilly Migraine Headache Drugs Product and Solutions

2.6.4 Eli Lilly Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Eli Lilly Recent Developments and Future Plans

2.7 Teva

2.7.1 Teva Details

2.7.2 Teva Major Business

2.7.3 Teva Migraine Headache Drugs Product and Solutions

2.7.4 Teva Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Teva Recent Developments and Future Plans

2.8 AstraZeneca

2.8.1 AstraZeneca Details

2.8.2 AstraZeneca Major Business

2.8.3 AstraZeneca Migraine Headache Drugs Product and Solutions

2.8.4 AstraZeneca Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 AstraZeneca Recent Developments and Future Plans

2.9 Sun Pharma

2.9.1 Sun Pharma Details

2.9.2 Sun Pharma Major Business

2.9.3 Sun Pharma Migraine Headache Drugs Product and Solutions

2.9.4 Sun Pharma Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Sun Pharma Recent Developments and Future Plans

2.10 Grunenthal

2.10.1 Grunenthal Details

2.10.2 Grunenthal Major Business

2.10.3 Grunenthal Migraine Headache Drugs Product and Solutions

2.10.4 Grunenthal Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Grunenthal Recent Developments and Future Plans

2.11 Endo Pharmaceuticals

2.11.1 Endo Pharmaceuticals Details

2.11.2 Endo Pharmaceuticals Major Business

2.11.3 Endo Pharmaceuticals Migraine Headache Drugs Product and Solutions

2.11.4 Endo Pharmaceuticals Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Endo Pharmaceuticals Recent Developments and Future Plans

2.12 Mylan

2.12.1 Mylan Details

2.12.2 Mylan Major Business

2.12.3 Mylan Migraine Headache Drugs Product and Solutions

2.12.4 Mylan Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Mylan Recent Developments and Future Plans

2.13 Bayer

2.13.1 Bayer Details

2.13.2 Bayer Major Business

2.13.3 Bayer Migraine Headache Drugs Product and Solutions

2.13.4 Bayer Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Bayer Recent Developments and Future Plans

2.14 Amneal Pharmaceuticals

2.14.1 Amneal Pharmaceuticals Details

2.14.2 Amneal Pharmaceuticals Major Business

2.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Product and Solutions

2.14.4 Amneal Pharmaceuticals Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Amneal Pharmaceuticals Recent Developments and Future Plans

2.15 Apotex

2.15.1 Apotex Details

2.15.2 Apotex Major Business

2.15.3 Apotex Migraine Headache Drugs Product and Solutions

2.15.4 Apotex Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Apotex Recent Developments and Future Plans

2.16 Ajanta Pharma

2.16.1 Ajanta Pharma Details

2.16.2 Ajanta Pharma Major Business

2.16.3 Ajanta Pharma Migraine Headache Drugs Product and Solutions

2.16.4 Ajanta Pharma Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Ajanta Pharma Recent Developments and Future Plans

2.17 Allergan

2.17.1 Allergan Details

2.17.2 Allergan Major Business

2.17.3 Allergan Migraine Headache Drugs Product and Solutions

2.17.4 Allergan Migraine Headache Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Allergan Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Migraine Headache Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Migraine Headache Drugs Players Market Share in 2021

3.2.2 Top 10 Migraine Headache Drugs Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Migraine Headache Drugs Players Head Office, Products and Services Provided

3.4 Migraine Headache Drugs Mergers & Acquisitions

3.5 Migraine Headache Drugs New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Migraine Headache Drugs Revenue and Market Share by Type (2017-2022)

4.2 Global Migraine Headache Drugs Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Migraine Headache Drugs Revenue Market Share by Application (2017-2022)

5.2 Global Migraine Headache Drugs Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Migraine Headache Drugs Revenue by Type (2017-2028)

6.2 North America Migraine Headache Drugs Revenue by Application (2017-2028)

6.3 North America Migraine Headache Drugs Market Size by Country

6.3.1 North America Migraine Headache Drugs Revenue by Country (2017-2028)

6.3.2 United States Migraine Headache Drugs Market Size and Forecast (2017-2028)

6.3.3 Canada Migraine Headache Drugs Market Size and Forecast (2017-2028)

6.3.4 Mexico Migraine Headache Drugs Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Migraine Headache Drugs Revenue by Type (2017-2028)

7.2 Europe Migraine Headache Drugs Revenue by Application (2017-2028)

7.3 Europe Migraine Headache Drugs Market Size by Country

7.3.1 Europe Migraine Headache Drugs Revenue by Country (2017-2028)

7.3.2 Germany Migraine Headache Drugs Market Size and Forecast (2017-2028)

7.3.3 France Migraine Headache Drugs Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Migraine Headache Drugs Market Size and Forecast (2017-2028)

7.3.5 Russia Migraine Headache Drugs Market Size and Forecast (2017-2028)

7.3.6 Italy Migraine Headache Drugs Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Migraine Headache Drugs Revenue by Type (2017-2028)

8.2 Asia-Pacific Migraine Headache Drugs Revenue by Application (2017-2028)

8.3 Asia-Pacific Migraine Headache Drugs Market Size by Region

8.3.1 Asia-Pacific Migraine Headache Drugs Revenue by Region (2017-2028)

8.3.2 China Migraine Headache Drugs Market Size and Forecast (2017-2028)

8.3.3 Japan Migraine Headache Drugs Market Size and Forecast (2017-2028)

8.3.4 South Korea Migraine Headache Drugs Market Size and Forecast (2017-2028)

8.3.5 India Migraine Headache Drugs Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Migraine Headache Drugs Market Size and Forecast (2017-2028)

8.3.7 Australia Migraine Headache Drugs Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Migraine Headache Drugs Revenue by Type (2017-2028)

9.2 South America Migraine Headache Drugs Revenue by Application (2017-2028)

9.3 South America Migraine Headache Drugs Market Size by Country

9.3.1 South America Migraine Headache Drugs Revenue by Country (2017-2028)

9.3.2 Brazil Migraine Headache Drugs Market Size and Forecast (2017-2028)

9.3.3 Argentina Migraine Headache Drugs Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Migraine Headache Drugs Revenue by Type (2017-2028)

10.2 Middle East & Africa Migraine Headache Drugs Revenue by Application (2017-2028)

10.3 Middle East & Africa Migraine Headache Drugs Market Size by Country

10.3.1 Middle East & Africa Migraine Headache Drugs Revenue by Country (2017-2028)

10.3.2 Turkey Migraine Headache Drugs Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Migraine Headache Drugs Market Size and Forecast (2017-2028)

10.3.4 UAE Migraine Headache Drugs Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Migraine Headache Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Migraine Headache Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Migraine Headache Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Migraine Headache Drugs Revenue (USD Million) by Region (2017-2022)

Table 5. Global Migraine Headache Drugs Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Migraine Headache Drugs Product and Solutions

Table 9. Pfizer Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Migraine Headache Drugs Product and Solutions

Table 13. Novartis Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 15. Johnson & Johnson Major Business

Table 16. Johnson & Johnson Migraine Headache Drugs Product and Solutions

Table 17. Johnson & Johnson Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. GSK Corporate Information, Head Office, and Major Competitors

Table 19. GSK Major Business

Table 20. GSK Migraine Headache Drugs Product and Solutions

Table 21. GSK Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Merck Corporate Information, Head Office, and Major Competitors

Table 23. Merck Major Business

Table 24. Merck Migraine Headache Drugs Product and Solutions

Table 25. Merck Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 27. Eli Lilly Major Business

Table 28. Eli Lilly Migraine Headache Drugs Product and Solutions

Table 29. Eli Lilly Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Teva Corporate Information, Head Office, and Major Competitors

Table 31. Teva Major Business

Table 32. Teva Migraine Headache Drugs Product and Solutions

Table 33. Teva Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 35. AstraZeneca Major Business

Table 36. AstraZeneca Migraine Headache Drugs Product and Solutions

Table 37. AstraZeneca Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Sun Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Sun Pharma Major Business

Table 40. Sun Pharma Migraine Headache Drugs Product and Solutions

Table 41. Sun Pharma Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Grunenthal Corporate Information, Head Office, and Major Competitors

Table 43. Grunenthal Major Business

Table 44. Grunenthal Migraine Headache Drugs Product and Solutions

Table 45. Grunenthal Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Endo Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 47. Endo Pharmaceuticals Major Business

Table 48. Endo Pharmaceuticals Migraine Headache Drugs Product and Solutions

Table 49. Endo Pharmaceuticals Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Mylan Corporate Information, Head Office, and Major Competitors

Table 51. Mylan Major Business

Table 52. Mylan Migraine Headache Drugs Product and Solutions

Table 53. Mylan Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Bayer Corporate Information, Head Office, and Major Competitors

Table 55. Bayer Major Business

Table 56. Bayer Migraine Headache Drugs Product and Solutions

Table 57. Bayer Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Amneal Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 59. Amneal Pharmaceuticals Major Business

Table 60. Amneal Pharmaceuticals Migraine Headache Drugs Product and Solutions

Table 61. Amneal Pharmaceuticals Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Apotex Corporate Information, Head Office, and Major Competitors

Table 63. Apotex Major Business

Table 64. Apotex Migraine Headache Drugs Product and Solutions

Table 65. Apotex Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Ajanta Pharma Corporate Information, Head Office, and Major Competitors

Table 67. Ajanta Pharma Major Business

Table 68. Ajanta Pharma Migraine Headache Drugs Product and Solutions

Table 69. Ajanta Pharma Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Allergan Corporate Information, Head Office, and Major Competitors

Table 71. Allergan Major Business

Table 72. Allergan Migraine Headache Drugs Product and Solutions

Table 73. Allergan Migraine Headache Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Global Migraine Headache Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 75. Global Migraine Headache Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 76. Breakdown of Migraine Headache Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Migraine Headache Drugs Players Head Office, Products and Services Provided

Table 78. Migraine Headache Drugs Mergers & Acquisitions in the Past Five Years

Table 79. Migraine Headache Drugs New Entrants and Expansion Plans

Table 80. Global Migraine Headache Drugs Revenue (USD Million) by Type (2017-2022)

Table 81. Global Migraine Headache Drugs Revenue Share by Type (2017-2022)

Table 82. Global Migraine Headache Drugs Revenue Forecast by Type (2023-2028)

Table 83. Global Migraine Headache Drugs Revenue by Application (2017-2022)

Table 84. Global Migraine Headache Drugs Revenue Forecast by Application (2023-2028)

Table 85. North America Migraine Headache Drugs Revenue by Type (2017-2022) & (USD Million)

Table 86. North America Migraine Headache Drugs Revenue by Type (2023-2028) & (USD Million)

Table 87. North America Migraine Headache Drugs Revenue by Application (2017-2022) & (USD Million)

Table 88. North America Migraine Headache Drugs Revenue by Application (2023-2028) & (USD Million)

Table 89. North America Migraine Headache Drugs Revenue by Country (2017-2022) & (USD Million)

Table 90. North America Migraine Headache Drugs Revenue by Country (2023-2028) & (USD Million)

Table 91. Europe Migraine Headache Drugs Revenue by Type (2017-2022) & (USD Million)

Table 92. Europe Migraine Headache Drugs Revenue by Type (2023-2028) & (USD Million)

Table 93. Europe Migraine Headache Drugs Revenue by Application (2017-2022) & (USD Million)

Table 94. Europe Migraine Headache Drugs Revenue by Application (2023-2028) & (USD Million)

Table 95. Europe Migraine Headache Drugs Revenue by Country (2017-2022) & (USD Million)

Table 96. Europe Migraine Headache Drugs Revenue by Country (2023-2028) & (USD Million)

Table 97. Asia-Pacific Migraine Headache Drugs Revenue by Type (2017-2022) & (USD Million)

Table 98. Asia-Pacific Migraine Headache Drugs Revenue by Type (2023-2028) & (USD Million)

Table 99. Asia-Pacific Migraine Headache Drugs Revenue by Application (2017-2022) & (USD Million)

Table 100. Asia-Pacific Migraine Headache Drugs Revenue by Application (2023-2028) & (USD Million)

Table 101. Asia-Pacific Migraine Headache Drugs Revenue by Region (2017-2022) & (USD Million)

Table 102. Asia-Pacific Migraine Headache Drugs Revenue by Region (2023-2028) & (USD Million)

Table 103. South America Migraine Headache Drugs Revenue by Type (2017-2022) & (USD Million)

Table 104. South America Migraine Headache Drugs Revenue by Type (2023-2028) & (USD Million)

Table 105. South America Migraine Headache Drugs Revenue by Application (2017-2022) & (USD Million)

Table 106. South America Migraine Headache Drugs Revenue by Application (2023-2028) & (USD Million)

Table 107. South America Migraine Headache Drugs Revenue by Country (2017-2022) & (USD Million)

Table 108. South America Migraine Headache Drugs Revenue by Country (2023-2028) & (USD Million)

Table 109. Middle East & Africa Migraine Headache Drugs Revenue by Type (2017-2022) & (USD Million)

Table 110. Middle East & Africa Migraine Headache Drugs Revenue by Type (2023-2028) & (USD Million)

Table 111. Middle East & Africa Migraine Headache Drugs Revenue by Application (2017-2022) & (USD Million)

Table 112. Middle East & Africa Migraine Headache Drugs Revenue by Application (2023-2028) & (USD Million)

Table 113. Middle East & Africa Migraine Headache Drugs Revenue by Country (2017-2022) & (USD Million)

Table 114. Middle East & Africa Migraine Headache Drugs Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Migraine Headache Drugs Picture

Figure 2. Global Migraine Headache Drugs Revenue Market Share by Type in 2021

Figure 3. Almotriptan

Figure 4. Eletriptan

Figure 5. Sumatriptan

Figure 6. Rizatriptan

Figure 7. Zolmitriptan

Figure 8. Naratriptan

Figure 9. Frovatriptan

Figure 10. Others

Figure 11. Migraine Headache Drugs Revenue Market Share by Application in 2021

Figure 12. Acute Migraine Picture

Figure 13. Common Migraine Picture

Figure 14. Classic Migraine Picture

Figure 15. Chronic Migraine Picture

Figure 16. Other Migraines Picture

Figure 17. Global Migraine Headache Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 18. Global Migraine Headache Drugs Revenue and Forecast (2017-2028) & (USD Million)

Figure 19. Global Migraine Headache Drugs Revenue Market Share by Region (2017-2028)

Figure 20. Global Migraine Headache Drugs Revenue Market Share by Region in 2021

Figure 21. North America Migraine Headache Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Europe Migraine Headache Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Asia-Pacific Migraine Headache Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. South America Migraine Headache Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 25. Middle East and Africa Migraine Headache Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 26. Migraine Headache Drugs Market Drivers

Figure 27. Migraine Headache Drugs Market Restraints

Figure 28. Migraine Headache Drugs Market Trends

Figure 29. Pfizer Recent Developments and Future Plans

Figure 30. Novartis Recent Developments and Future Plans

Figure 31. Johnson & Johnson Recent Developments and Future Plans

Figure 32. GSK Recent Developments and Future Plans

Figure 33. Merck Recent Developments and Future Plans

Figure 34. Eli Lilly Recent Developments and Future Plans

Figure 35. Teva Recent Developments and Future Plans

Figure 36. AstraZeneca Recent Developments and Future Plans

Figure 37. Sun Pharma Recent Developments and Future Plans

Figure 38. Grunenthal Recent Developments and Future Plans

Figure 39. Endo Pharmaceuticals Recent Developments and Future Plans

Figure 40. Mylan Recent Developments and Future Plans

Figure 41. Bayer Recent Developments and Future Plans

Figure 42. Amneal Pharmaceuticals Recent Developments and Future Plans

Figure 43. Apotex Recent Developments and Future Plans

Figure 44. Ajanta Pharma Recent Developments and Future Plans

Figure 45. Allergan Recent Developments and Future Plans

Figure 46. Global Migraine Headache Drugs Revenue Share by Players in 2021

Figure 47. Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 48. Global Top 3 Players Migraine Headache Drugs Revenue Market Share in 2021

Figure 49. Global Top 10 Players Migraine Headache Drugs Revenue Market Share in 2021

Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 51. Global Migraine Headache Drugs Revenue Share by Type in 2021

Figure 52. Global Migraine Headache Drugs Market Share Forecast by Type (2023-2028)

Figure 53. Global Migraine Headache Drugs Revenue Share by Application in 2021

Figure 54. Global Migraine Headache Drugs Market Share Forecast by Application (2023-2028)

Figure 55. North America Migraine Headache Drugs Sales Market Share by Type (2017-2028)

Figure 56. North America Migraine Headache Drugs Sales Market Share by Application (2017-2028)

Figure 57. North America Migraine Headache Drugs Revenue Market Share by Country (2017-2028)

Figure 58. United States Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Canada Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Mexico Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Europe Migraine Headache Drugs Sales Market Share by Type (2017-2028)

Figure 62. Europe Migraine Headache Drugs Sales Market Share by Application (2017-2028)

Figure 63. Europe Migraine Headache Drugs Revenue Market Share by Country (2017-2028)

Figure 64. Germany Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. France Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. United Kingdom Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Russia Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Italy Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Asia-Pacific Migraine Headache Drugs Sales Market Share by Type (2017-2028)

Figure 70. Asia-Pacific Migraine Headache Drugs Sales Market Share by Application (2017-2028)

Figure 71. Asia-Pacific Migraine Headache Drugs Revenue Market Share by Region (2017-2028)

Figure 72. China Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Japan Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. South Korea Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. India Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Southeast Asia Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Australia Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. South America Migraine Headache Drugs Sales Market Share by Type (2017-2028)

Figure 79. South America Migraine Headache Drugs Sales Market Share by Application (2017-2028)

Figure 80. South America Migraine Headache Drugs Revenue Market Share by Country (2017-2028)

Figure 81. Brazil Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Argentina Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Middle East and Africa Migraine Headache Drugs Sales Market Share by Type (2017-2028)

Figure 84. Middle East and Africa Migraine Headache Drugs Sales Market Share by Application (2017-2028)

Figure 85. Middle East and Africa Migraine Headache Drugs Revenue Market Share by Country (2017-2028)

Figure 86. Turkey Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Saudi Arabia Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 88. UAE Migraine Headache Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. Methodology

Figure 90. Research Process and Data Source